# PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

> **NCT06173349** · PHASE1 · RECRUITING · sponsor: **University of California, Davis** · enrollment: 12 (estimated)

## Conditions studied

- Recurrent Non-Muscle Invasive Bladder Carcinoma
- Stage 0a Bladder Cancer AJCC v8
- Stage 0is Bladder Cancer AJCC v8
- Stage I Bladder Cancer AJCC v8

## Interventions

- **DRUG:** PLZ4-coated paclitaxel loaded micelles (PPM)

## Key facts

- **NCT ID:** NCT06173349
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-22
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06173349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06173349, "PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06173349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*